Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

GRAS Notices
  • Print
  • Share
  • E-mail
-

GRN No. 406

1,4-α-glucan branching enzyme preparation from Bacillus subtilis strain 168 expressing the glucan branching enzyme gene from Aquifex aeolicus strain VF5

Intended Use: As an enzyme in the production of cyclic dextran and enzymatically-synthesized glycogen
Basis: Scientific procedures
Notifier: Ezaki Glico Co., Ltd.
Notifier Address: 4-6-5, Utajima Nishioyogogawa
Osaka
JAPAN
Date of filing: Oct 11, 2011
GRAS Notice (releasable information): GRN 406 (in PDF)
Date of closure: Sep 11, 2012
Date of FDA’s corrected letter: Nov 1, 2012
FDA's Letter: FDA has no questions
-
-